These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4445556)

  • 21. [Therapeutic activity in gastric and duodenal ulcers, gastritis and gastroduodenitis of an anti-secretory, non-anticholinergic drug].
    Bianchi PG; Saccabusi E
    Minerva Med; 1969 Mar; 60(23):1044-52. PubMed ID: 5781331
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapy of some conditions of chronic gastroduodenitis and of gastroduodenal ulcer with a preparation, for intravenous or intramuscular injection or oral administration, derived from a carboxyl halicyclic acid].
    Abbona C; Gatto PL; Bezante GC
    Minerva Med; 1967 Oct; 58(86):3691-9. PubMed ID: 6061063
    [No Abstract]   [Full Text] [Related]  

  • 23. [Results of double-blind study with anticholinergic drugs].
    Pisani W; Cigliati G; Giachino GM
    Minerva Med; 1973 Apr; 64(23):1180-2. PubMed ID: 4736090
    [No Abstract]   [Full Text] [Related]  

  • 24. [Current aspects in the treatment of gastroduodenal ulcers and related diseases. Results of a field study on sulpiride (Dogmatil) in ambulatory practice].
    Lembeck K; Weinert D
    ZFA (Stuttgart); 1976 Aug; 52(24):1255-9. PubMed ID: 785854
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic activity of sulpiride in gastroduodenal ulcer].
    Gallioli G; Grassi E
    Minerva Med; 1974 Oct; 65(73):3843-9. PubMed ID: 4423611
    [No Abstract]   [Full Text] [Related]  

  • 26. [Xylamide as a gastrotrophic and gastroprotective agent in the treatment of gastroduodenal ulcer disease].
    Galeone M; Doldi SB; Fichera G; Bastagli A
    Minerva Gastroenterol; 1970; 16(2):70-93. PubMed ID: 5477401
    [No Abstract]   [Full Text] [Related]  

  • 27. [A comparative evaluation of the antacid properties of the preparations Maalox and Almagel].
    Grebenev AL; Sheptulin AA; Okhlobystin AV
    Ter Arkh; 1994; 66(8):44-7. PubMed ID: 7985154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Possibilities of the use of present-day antisecretory preparation omeprazole].
    Degtiareva II; Semeunovich S; Kharchenko NV; Petrovich S; Gaĭsenko AV; Egorova IT
    Klin Med (Mosk); 1994; 72(6):38-40. PubMed ID: 7898006
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of sulpiride in organic and functional digestive pathology].
    Geoffroy H; Bajolet S; Coudoux P; Brunois JP; Chardon P; Behar C; Dalle M; Deroche B
    Sem Hop; 1970 Jun; 46(29):Suppl:23-9. PubMed ID: 4316824
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect, on gastric absorption, of a new molecule with mucopoietic activity, 2-)p-methylsulfonylphenyl)-imidazo (1,2-a) pyridine, used in therapy of gastroduodenal diseases].
    Barlattani M
    Clin Ter; 1971 Dec; 59(5):417-30. PubMed ID: 5159600
    [No Abstract]   [Full Text] [Related]  

  • 31. Campylobacter pylori and gastroduodenal ulcer disease. A prospective study in a Swedish population.
    Gad A; Hradsky M; Furugård K; Malmodin B
    Scand J Gastroenterol Suppl; 1989; 167():81-5. PubMed ID: 2575789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and experimental data on some secretory functional aspects of the stomach in patients with gastrointestinal diseases treated with a gel of aluminum or magnesium hydroxide in a colloidal suspension ("Maalox")].
    Abbona C; Gatto PL; Bezante GC
    Minerva Gastroenterol; 1969; 15(2):86-93. PubMed ID: 5815483
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical trials of a pharmacological perparation in the therapy of ulcerous gastroduodenitis].
    Linati E
    Minerva Med; 1969 Mar; 60(23):1038-43. PubMed ID: 5781330
    [No Abstract]   [Full Text] [Related]  

  • 34. [Xylamide (Milid) therapy of gastroduodenitis in patients with saturnism].
    Gambini G; Grisler R
    Minerva Med; 1969 Mar; 60(23):1017-23. PubMed ID: 5781327
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of gastroduodenal ulcer with plasmutan].
    Berard E; Gallavardin M
    Med Chir Dig; 1975; 4(1):57-60. PubMed ID: 1160427
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of propaxoline therapy on gastroduodenal inflammation. Radiological, endoscopic, bioptic and functional studies of the stomach and duodenum].
    Gasbarrini G; Faggioli F; Melchionda N; Miglio F; Zanetti A
    Minerva Med; 1970 Sep; 61(71):3643-66. PubMed ID: 5454749
    [No Abstract]   [Full Text] [Related]  

  • 37. [The role of sulpiride in the therapeutic strategy of severe gastro-duodenal ulcers in surgery].
    Leguyader A
    Med Chir Dig; 1976; 5(4):255-8. PubMed ID: 950827
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of gastro-duodenal ulcer, gastritis and gastroduodenitis with an antisecretory, non-anticholinergic drug (Milid)].
    Borellini D; Milvio C
    Minerva Med; 1969 Mar; 60(23):1053-6. PubMed ID: 5781332
    [No Abstract]   [Full Text] [Related]  

  • 39. Caved-S and Ulcedal for peptic ulcer.
    Drug Ther Bull; 1973 Feb; 11(3):10-2. PubMed ID: 4571693
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of peptic ulcer using antacids and anxiolytic agents. Results after prolonged treatment].
    Michetti P; De Conca V
    Clin Ter; 1976 Sep; 78(5):463-9. PubMed ID: 12908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.